Clinical Trial Update: Prognostic Value of PARS Classification for Locally Recurrent Rectal Cancer

View source ↗

Summary

A completed clinical trial evaluating whether PARS classification has prognostic value for locally recurrent rectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Local Recurrence of Malignant Tumor of Rectum | Status: COMPLETED